Ethical Code
A critical factor in Proteomika's clinical research is obtaining biological samples from patients and control groups. Proteomika establishes networks of multi-centre clinics and has undertaken over 30 observational studies in different stages of recruitment in different national and international medical centres. As a result, we have access to all types of biological samples for the study of new biomarkers and the validation of diagnostic methods that are currently under development.
The value of a biological sample is based on its quality and the clinical information that is associated to it. Both variables significantly affect the quality of the obtained results. Therefore, Proteomika works closely with the best specialists in order to define the clinical and experimental design that is best suited for each study.
Proteomika is committed to the use of the strictest ethical rules for the handling of clinical samples and information. This is a compelling obligation and we rigorously comply with both international ethical codes as well as with the observance of law.
Proteomika complies with the Helsinki Declaration principles, thus all clinical assays require the approval of Ethical and Research Committees of each participating centre. Its researchers are bound to guarantee the correct execution of the study based on the protocol that has been approved by the CEIC and to follow all applicable ethical rules.
Proteomika guarantees complete confidentiality of the clinical information that is obtained in studies in compliance with Law 15/1999, of 13 December, on the Protection of Personal Data and Law 41/2002, of 14 November, on the autonomy of the patient and the rights and obligations pertaining clinical information and documentation.